PRIMARY OVERALL SURVIVAL ANALYSIS OF THE PHASE 3 RANDOMIZED ZUMA‐7 STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA

Abstract

Open access

Peer reviewed

J. R. Westin, O. O. Oluwole, M. J. Kersten, D. B. Miklos, M.‐A. Perales, A. Ghobadi, A. P. Rapoport, A. Sureda, C. A. Jacobson, U. Farooq, …

Hematological oncology, Vol.41(S2), pp.52-54

06/2023

DOI: 10.1002/hon.3163_22

Files and links (1)

url

https://doi.org/10.1002/hon.3163_22View

Published (Version of record) Open Access

Title: Subtitle: PRIMARY OVERALL SURVIVAL ANALYSIS OF THE PHASE 3 RANDOMIZED ZUMA‐7 STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA
Creators: J. R. Westin - The University of Texas MD Anderson Cancer Center
O. O. Oluwole - Vanderbilt University
M. J. Kersten - University of Amsterdam
D. B. Miklos - Stanford University
M.‐A. Perales - Memorial Sloan Kettering Cancer Center
A. Ghobadi - Washington University in St. Louis
A. P. Rapoport - University of Maryland, Baltimore
A. Sureda - Institut Català d'Oncologia
C. A. Jacobson - Dana-Farber Cancer Institute
U. Farooq - University of Iowa
T. van Meerten - University Medical Center Groningen
M. L. Ulrickson - Banner MD Anderson Cancer Center, Gilbert, Arizona, USA
M. Elsawy - Dalhousie University
L. A. Leslie - Hackensack University Medical Center
S. Chaganti - University Hospitals Birmingham NHS Foundation Trust
M. Dickinson - The University of Melbourne
Y. Yang - Kite (United States)
M. Schupp - Kite (United States)
C. To - Kite (United States)
F. L. Locke - Moffitt Cancer Center
Resource Type: Abstract
Publication Details: Hematological oncology, Vol.41(S2), pp.52-54
DOI: 10.1002/hon.3163_22
ISSN: 0278-0232
eISSN: 1099-1069
Language: English
Date published: 06/2023
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984442960102771

6 Record Views